U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07144813) titled 'Post-Approval Study of the Neuspera Sacral Neuromodulation System' on Aug. 25.
Brief Summary: Prospective, multi-center, single-arm, post-approval study is designed to assess the long-term safety and efficacy data of the Neuspera Sacral Neuromodulation (SNM) System following commercial approval of the Neuspera SNM System.
Participants in this study received intervention/implanted in Phase I or Phase II of the Neuspera SANS\_UUI (NSM-004) Study.
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Urinary Urgency Incontinence
Intervention:
DEVICE: Neuspera Implantable Sacral Neuromodulation System
Stimulation o...